Revolutionizing Clinical Trials: Faro Health Secures $20 Million in Funding for Innovative Platform

We are excited to announce that Faro Health, an innovative leader in clinical trial technology, has successfully raised $20 million in its latest funding round. Faro Health leverages cutting-edge, cloud-based software to transform the design and optimization of clinical trial protocols, allowing clinical development teams to focus on what they do best. By streamlining tedious, manual processes, Faro’s platform enables teams to create optimized clinical protocols in a digital-native environment. This new infusion of capital will be pivotal in advancing our mission to reduce the burden that clinical research places on patients and clinicians alike. With this funding, Faro Health plans to enhance its technological capabilities, invest in further software development, and expand our team of experts dedicated to improving the clinical trial landscape. The insights generated by our platform not only lower clinical trial costs and simplify study complexities but also set the stage for a more efficient data flow and automation of processes downstream. As we continue to innovate and refine our solutions, our commitment to improving patient experiences and outcomes through thoughtful protocol design remains unwavering. This funding milestone is not just a testament to our progress, but also a significant step toward reshaping the future of clinical research. We look forward to leveraging this investment to drive further advancements in the industry and improve the efficiency and effectiveness of clinical trials for researchers and participants alike.